Background
Methods
Study setting
Specimen collection, identification and antimicrobial susceptibility testing
Molecular identification of ESBL genes
PCR detection of Escherichia coli phylogroups and ST131
Statistical analysis
Results
Occurrence of ESBL-producing enterobacteriaceae
Outpatients (n = 150) | Inpatients (n = 158) | |||||||
---|---|---|---|---|---|---|---|---|
Variable | ESBL-positive | ESBL-negative | Odds Ratio (95 % CI) | P-value | ESBL-positive | ESBL-negative | Odds Ratio (95 % CI) | P-value |
(n = 68) | (n = 82) | (n = 111) | (n = 47) | |||||
Sex | <0.001 | 0.724 | ||||||
F (n = 129) | 16 | 48 | 1 | 47 | 18 | 1 | ||
M (n = 179) | 52 | 34 | 4.59 (2.14–9.84) | 64 | 29 | 0.85 (0.42–1.70) | ||
Source of isolates | 0.019 | 0.139 | ||||||
Urine sample (n–185) | 59 | 60 | 1 | 48 | 18 | 1 | ||
Pus (n = 56) | 06 | 07 | 0.87 (0.28–2.75) | 32 | 11 | 1.09 (0.46–2.61) | ||
Aspirate (n = 38) | 02 | 03 | 0.68 (0.11–4.20) | 24 | 09 | 1.00 (0.39–2.56) | ||
Othera (n = 29) | 01 | 12 | 0.08 (0.01–0.67) | 07 | 09 | 0.29 (0.09–0.90) | ||
Age | <0.001 | 0.607 | ||||||
≤28 days | 01 | 02 | 1 | 09 | 04 | 1 | ||
>28 days–1 year | 01 | 08 | 0.20 (0.01–4.72) | 07 | 04 | 0.78 (0.14–4.27) | ||
>1–5 years | 02 | 15 | 0.31 (0.02–5.19) | 06 | 06 | 0.44 (0.09–2.28) | ||
>5–15 years | 04 | 07 | 1.14 (0.08–16.95) | 30 | 12 | 1.11 (0.29–4.31) | ||
>15–65 years | 44 | 45 | 1.96 (0.17–22.35) | 49 | 19 | 1.15 (0.32–4.17) | ||
>65 years | 16 | 05 | 6.40 (0.47–86.34) | 10 | 02 | 2.22 (0.33–15.18) |
Distribution of ESBL-producing isolates in samples (%) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Species | Within species | Total | Urine | Stool | Blood | Pus | Aspirates | HVS | CSF |
(%) | (n = 185) | (n = 16) | (n = 18) | (n = 56 | (n = 38) | (n = 3) | (n = 2) | ||
Escherichia coli
| 121/202 (60 %) | 67.5 % | 67/114 | 0/15 | 0 | 29/39 | 23/31 | 2/2 | 0/1 |
Klebsiella pneumonia
| 46/70 (66 %) | 26 % | 32/51 | 0 | 5/6 | 6/8 | 3/4 | 0/1 | 0 |
Enterobacter cloacae
| 7/13 (54 %) | 4 % | 6/10 | 0 | 0 | 1/3 | 0 | 0 | 0 |
Enterobacter aerogenes
| 1/3 (33 %) | 0.5 % | 1/2 | 0 | 0 | 0 | 0/1 | 0 | 0 |
Citrobacter koseri
| 0/1 | – | 0 | 0 | 0 | 0 | 0/1 | 0 | 0 |
Citrobacter freundi
| 1/3 (33 %) | 0.5 % | 1 /2 | 0 | 0 | 0/1 | 0 | 0 | 0 |
Proteus mirabilis
| 0/5 | – | 0/4 | 0 | 0 | 0/1 | 0 | 0 | 0 |
Providencia stuartii
| 2/6 (33 %) | 1 % | 0/1 | 0 | 1/1 | 1/3 | 0/1 | 0 | 0 |
Salmonella spp
| 0/3 | – | 0 | 0/1 | 0/1 | 0 | 0 | 0 | 0/1 |
Morganella morgannii
| 1/1 (100 %) | 0.5 % | 0 | 0 | 0 | 1/1 | 0 | 0 | 0 |
Leclercia adecarboxylata
| 0/1 | – | 0/1 | 0 | 0 | 0 | 0 | 0 | 0 |
Total (%) | 179/308 (58 %) | 100 % | 107/185 | 0/16 | 6/8 | 38/56 | 26/38 | 2/3 | 0/2 |
Antibiotic susceptibility patterns
Molecular characterization of ESBL and other ß-lactamase genes
Outpatients (n = 68) | Inpatients (n = 111) | ||||
---|---|---|---|---|---|
Isolates (n) | Hospital (n) | ESBL Type | Other ß-lactamases | ESBL Types | Other ß-lactamases |
Escherichia coli (121) | CHU-YO (37) | CTX-M-15 (1) | OXA-1(1) | CTX-M-14 (1) | SHV-1, TEM −1 (1) |
CTX-M-15 (2) | SHV-1 (2) | CTX-M-14 (1) | TEM-1 (1) | ||
CTX-M-15 (1) | TEM-1 (1) | CTX-M-15 (3) | TEM-1, OXA-1 (3) | ||
CTX-M-15 (1) | – | CTX-M-15 (7) | TEM-1(7) | ||
– | – | CTX-M-15 (3) | SHV-1 (3) | ||
– | – | CTX-M-15 (12) | OXA-1 (12) | ||
– | – | CTX-M-15 (3) | – | ||
– | – | CTX-M-27 (2) | TEM-1 (2) | ||
CHUSS (52) | CTX-M-15 (3) | SHV-1, OXA-1 (3) | CTX-M-15 (1) | SHV-1, OXA-1 (1) | |
CTX-M-15 (1) | TEM-1, OXA-1 (1) | CTX-M-15 (1) | TEM-1, OXA-1 (1) | ||
CTX-M-15 (2) | TEM-1 (2) | CTX-M-15 (1) | TEM-1 (1) | ||
CTX-M-15 (27) | OXA-1 (27) | CTX-M-15 (15) | OXA-1 (15) | ||
SHV-12 (1) | – | – | – | ||
CHUP-CDG (32) | CTX-M-15 (1) | OXA-1 (1) | CTX-M-14 (2) | TEM-1, OXA-1 (2) | |
CTX-M-15 (4) | TEM-1(4) | CTX-M-15 (8) | TEM-1, OXA-1 (8) | ||
CTX-M-27 (1) | OXA-1, TEM-1(1) | CTX-M-15 (10) | TEM-1(10) | ||
– | – | CTX-M-15 (6) | OXA-1 (6) | ||
Klebsiella pneumonia (46) | CHU-YO (5) | CTX-M-15(1) | TEM-1, OXA-1(1) | CTX-M-15 (1) | SHV-1, OXA-1, TEM-1 (1) |
SHV-12 (1) | – | CTX-M-15 (2) | OXA-1 (2) | ||
CHUSS (24) | CTX-M-15(1) | SHV-1, OXA-1, TEM-1(1) | CTX-M-15(3) | SHV-1, OXA-1, TEM-1(3) | |
CTX-M-15(2) | SHV-1, OXA-1, (2) | CTX-M-15(2) | SHV-1, OXA-1 (2) | ||
CTX-M-15(3) | SHV-1, TEM-1 (3) | CTX-M-15(2) | OXA-1, TEM-1 (2) | ||
CTX-M-15(5) | OXA-1 (5) | CTX-M15 (2) | OXA-1 (2) | ||
CTX-M-15(1) | TEM-1(1) | CTX-M–15(1) | – | ||
CTX-M-15(2) | SHV-1 (2) | – | – | ||
CHUP-CDG (17) | CTX-M-15 (2) | OXA-1 (2) | CTX-M-15 (3) | OXA-1(3) | |
– | – | CTX-M-15 (5) | EM-1, OXA-1 (5) | ||
– | – | CTX-M-15(4) | SHV-1, TEM-1(4) | ||
– | – | CTX-M-15(2) | SHV-11 | ||
– | – | CTX-M-27(1) | SHV-1(1) | ||
Other strains (12) | CTX-M-15(2) | OXA-1, TEM-1 (2) | CTX-M-15 (5) | OXA-1, TEM-1 | |
CTX-M-15 (2) | TEM-1, SHV-1 (2) | CTX-M-15 (1) | SHV-11(1) | ||
CTX-M-27 (1) | OXA-1 (1) | CTXM-15 (1) | – |
Escherichia coli phylogenetic groups and sequence type 131
ESBL-Positive (n = 121) | ESBL-Negative (n = 81) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B1 | B2 | C | Clade I | D | F | Unknown | ST131 | A | B1 | B2 | C | Clade I | D | F | Unknown | ST131 | |
Hospital (number of samples) | ||||||||||||||||||
CHU-YO (55) | ||||||||||||||||||
Outpatients (16) | 0 | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 6 | 0 | 0 | 0 | 4 | 0 |
Inpatients (39) | 9 | 2 | 4 | 6 | 0 | 5 | 6 | 0 | 3 | 0 | 0 | 3 | 0 | 0 | 2 | 0 | 2 | 1 |
CHU-SS (90) | ||||||||||||||||||
Outpatients (59) | 6 | 1 | 11 | 4 | 2 | 8 | 1 | 0 | 8 | 7 | 2 | 7 | 4 | 1 | 3 | 2 | 0 | 4 |
Inpatients (31) | 7 | 1 | 5 | 1 | 0 | 3 | 1 | 1 | 4 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 3 | 0 |
CHUP-CDG (57) | ||||||||||||||||||
Outpatients (20) | 0 | 1 | 0 | 0 | 0 | 2 | 2 | 1 | 0 | 7 | 2 | 3 | 0 | 0 | 1 | 0 | 1 | 1 |
Inpatients (37) | 9 | 2 | 3 | 0 | 3 | 6 | 0 | 3 | 0 | 2 | 2 | 2 | 0 | 0 | 5 | 0 | 1 | 0 |